Search
for
Sort by
Research 30 of 79
- Mesalazine in the treatment of extensive alopecia areata: A new therapeutic option?
- Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients
- Alopecia areata incognita in Cronkhite-Canada syndrome
- Azathioprine-induced liver injury in a patient with multiple autoimmune syndrome
- Chemical Gastroenterocolitis after Dental Root Canal Therapy with Camphorated and Mentholated Chlorophenol
- Hair Loss and 5-Aminosalicylic Acid Enemas
- Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
- Frequency and associated factors of hair loss among patients with inflammatory bowel disease
- Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease
- ALOPECIA UNIVERSALIS IN ULCERATIVE COLITIS
- Pyoderma gangrenosum presented as generalized pustules in a patient with Crohn’s disease
- Community mental health and wellbeing: a case study
- Cronkhite–Canada syndrome: from clinical features to treatment
- Cases Report the Cronkhite-Canada Syndrome
- Enteral nutrition for maintenance of remission in Crohn's disease
- Visual Diagnosis
- Telogen effl uvium as the fi rst symptom of Crohn's disease in a child
- Symptom management in inflammatory bowel disease
- Drug Reactions Affecting Hair: Diagnosis
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Wnt signaling: the good and the bad
- Drug-Induced Hair Disorders
- Drug eruptions in dermatology
- Cronkhite-Canada syndrome associated with colon cancer metastatic to liver
- Generalized pruritus in primary sclerosing cholangitis: implications of histamine release by lysophosphatidic acid
- Development and Validation of Spectrophotometric Method for Determination of Finasteride in Pharmaceutical Formulation Using 1,2-Naphthoquine-4-sulfonate (NQS)
- Diseases of Hair and Nails
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment
- Pharmacotherapy of alopecia areata
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024